Louise E Phillips

Summary

Affiliation: Monash University
Country: Australia

Publications

  1. ncbi request reprint Uncontrolled bleeding in surgical patients: the role of recombinant activated factor VIIa
    L E Phillips
    Monash University, Department of Epidemiology and Preventive Medicine, Victoria, Australia
    Curr Drug Targets 10:744-70. 2009
  2. doi request reprint Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry
    Louise E Phillips
    Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Victoria 3004, Australia
    Anesth Analg 109:1908-15. 2009
  3. doi request reprint Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding
    Rangi K Kandane-Rathnayake
    Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    ANZ J Surg 83:155-60. 2013
  4. doi request reprint A review on decision support for massive transfusion: understanding human factors to support the implementation of complex interventions in trauma
    Joanne C Enticott
    Transfusion Outcomes Research Collaborative, Department of Epidemiology and Preventive Medicine, Monash University, Australia
    Transfusion 52:2692-705. 2012
  5. doi request reprint Off-label use of recombinant factor VIIa in pediatric patients
    Zoe K McQuilten
    Transfusion Research Unit, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    Pediatrics 129:e1533-40. 2012
  6. doi request reprint Clinical guidelines and off-license recombinant activated factor VII: content, use, and association with patient outcomes
    C D Willis
    Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    J Thromb Haemost 7:2016-22. 2009

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Uncontrolled bleeding in surgical patients: the role of recombinant activated factor VIIa
    L E Phillips
    Monash University, Department of Epidemiology and Preventive Medicine, Victoria, Australia
    Curr Drug Targets 10:744-70. 2009
    ..Indeed, the process of establishing efficacy, safety and regulation of a therapeutic that is increasingly used off-label is not without significant difficulties...
  2. doi request reprint Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry
    Louise E Phillips
    Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Victoria 3004, Australia
    Anesth Analg 109:1908-15. 2009
    ..Through the Australian and New Zealand Haemostasis Registry, we report on the Australian and New Zealand experience with recombinant activated factor VII (rFVIIa) in obstetric patients...
  3. doi request reprint Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding
    Rangi K Kandane-Rathnayake
    Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    ANZ J Surg 83:155-60. 2013
    ..Approximately 1.3% of the ANZHR patients were Jehovah's Witnesses (JWs). We compared them with the non-JW patients in the registry...
  4. doi request reprint A review on decision support for massive transfusion: understanding human factors to support the implementation of complex interventions in trauma
    Joanne C Enticott
    Transfusion Outcomes Research Collaborative, Department of Epidemiology and Preventive Medicine, Monash University, Australia
    Transfusion 52:2692-705. 2012
    ..Given the complexity of trauma resuscitation, implementing any intervention for decision support in MT is challenging and may benefit from a HFs-assisted approach...
  5. doi request reprint Off-label use of recombinant factor VIIa in pediatric patients
    Zoe K McQuilten
    Transfusion Research Unit, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    Pediatrics 129:e1533-40. 2012
    ..To examine off-label recombinant factor VIIa (rFVIIa) use in pediatric patients including clinical indications, dose, adverse events, and outcomes...
  6. doi request reprint Clinical guidelines and off-license recombinant activated factor VII: content, use, and association with patient outcomes
    C D Willis
    Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    J Thromb Haemost 7:2016-22. 2009
    ..Guidelines may therefore be useful for improving processes and outcomes. Little is known regarding guidelines for off-license rFVIIa or their association with patient outcomes...